Gamma Knife Market

Gamma knife sales will grow through 2036, led by brain metastasis at a 69.5% share, driven by rising incidence of brain metastases from primary cancers and growing preference for non-invasive radiosurgery. Head holds a 54.3% share. The market is set to reach USD 420.6 million by 2026-end and USD 875.0 million by 2036.